Mark A. Merkley

483 citations
16 papers · 381 indexed · h-index 11
Topics
Head and Neck Cancer Studies (7 papers)Cervical Cancer and HPV Research (3 papers)Salivary Gland Tumors Diagnosis and Treatment (3 papers)

In The Last Decade

Mark A. Merkley

16 papers receiving 373 citations

Peers

Mark A. Merkley
Comparison fields: 5 of 74
  • Molecular Biology 153
  • Otorhinolaryngology 148
  • Surgery 88
  • Oncology 78
  • Epidemiology 63
Replace Dorota Słonina with:
Dorota Słonina Poland
Pingdong Li China
Gianna Badaracco Italy
Jana Šmahelová Czechia
Y Tomita Japan
Hui Jia United Kingdom
Nina Milutin Gašperov Croatia
Linda Simmons-Arnold United States
Judit Czeglédy Hungary
F P Rugman United Kingdom
Mark A. Merkley relative to Dorota Słonina Poland Dorota Słonina's profile →
Citations per field
00.5×3.4×
Dorota Słonina · 1×
Citations per year

Countries citing papers authored by Mark A. Merkley

Since Specialization
Citations

This map shows the geographic impact of Mark A. Merkley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Merkley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Merkley more than expected).

Fields of papers citing papers by Mark A. Merkley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Merkley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Merkley. The network helps show where Mark A. Merkley may publish in the future.

Co-authorship network of co-authors of Mark A. Merkley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Merkley. A scholar is included among the top collaborators of Mark A. Merkley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Merkley. Mark A. Merkley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 30
2 44
3 33
4 24
5 1
6 7
7 47
8 3
9 7
10 1
11 69
12 23
13 19
14 16
15 39
16 18

About Mark A. Merkley

Mark A. Merkley is a scholar working on Otorhinolaryngology, Periodontics and Virology, having authored 16 papers that have together received 381 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (7 papers), Cervical Cancer and HPV Research (3 papers) and Salivary Gland Tumors Diagnosis and Treatment (3 papers). The work is most often cited by research in Otorhinolaryngology (148 citations), Virology (35 citations) and Periodontics (31 citations). Mark A. Merkley has collaborated with scholars based in United States, Peru and United Kingdom. Frequent co-authors include William S. Dynan, Jeffrey R. Lee, Paul Weinberger, Robert H. Podolsky, Amanda Psyrri, Hilal Arnouk, Hubert Stöppler, Steven R. Gill, Matthew C. Miller and Carlos Santos. Their work appears in journals such as Nucleic Acids Research, Cancer Research and Frontiers in Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026